Advances in Radiation Oncology (Jan 2021)

Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases

  • Matthew Chan, MD, FRCPC,
  • David Palma, MD, PhD, FRCPC,
  • Aisling Barry, MD, FRCPC,
  • Andrew Hope, MD, FRCPC,
  • Richard Moore, RCSI,
  • Melissa O’Neil, MRT(T),
  • Janet Papadakos, MEd, PhD,
  • Devin Schellenberg, MD, FRCPC,
  • Tony Tadic, PhD,
  • C. Jillian Tsai, MD, PhD,
  • Meredith Giuliani, MBBS, MEd, FRCPC

Journal volume & issue
Vol. 6, no. 1
p. 100499

Abstract

Read online

Purpose: With multiple phase 2 trials supporting the use of stereotactic body radiation therapy (SBRT) in oligo-metastatic disease, we evaluated practices that could inform effective implementation of an oligo-metastasis SBRT program. Methods and Materials: Using a context-focused realist methodology, an advisory committee of interprofessional clinicians met over a series of semistructured teleconference meetings to identify challenges in implementing an oligo-metastasis SBRT program. Consideration was given to 2 models of care: a subspecialist anatomic expertise model versus a single-practitioner “quarterback” model. Results: The advisory committee structured recommendations within a context-mechanism-outcome framework. In summary, the committee recommends that during patient workup, a single practitioner arranges the minimum number of necessary tests, with case presentation at an appropriate multidisciplinary tumor board, including careful review of all previous treatments, and enrollment on clinical trials when possible. At simulation, common patient positions and immobilization on a single simulation scan for multiple sites is recommended. During radiation planning, dose-fractionation regimens should safely facilitate cumulative dose calculations, a single isocenter should be considered for multiple close targets to reduce treatment time, and adherence to strict quality assurance protocols is strongly recommended. Treatment duration should be minimized by treating multiple sites on the same day or choosing shorter dose fractionations. Team communication, thorough documentation, and standardized nomenclature can reduce system errors. Follow-up should aim to minimize redundant clinical appointments and imaging scans. Expert radiology review may be required to interpret post-SBRT imaging. Conclusions: These guidelines inform best clinical practices for implementing an oligo-metastasis SBRT program. Iterations using a realist approach may further expand on local contexts.